$PSIX
POWER SOLUTIONS INTERNATIONAL, INC.

2021 Q1 Form 10-Q Financial Statement

#000113709121000005 Filed on May 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $100.2M $105.1M
YoY Change -4.69% -9.23%
Cost Of Revenue $93.10M $87.38M
YoY Change 6.54% -10.91%
Gross Profit $7.070M $17.71M
YoY Change -60.09% 0.06%
Gross Profit Margin 7.06% 16.85%
Selling, General & Admin $15.81M $13.89M
YoY Change 13.83% -13.51%
% of Gross Profit 223.64% 78.41%
Research & Development $6.224M $6.752M
YoY Change -7.82% 7.19%
% of Gross Profit 88.03% 38.12%
Depreciation & Amortization $1.266M $1.296M
YoY Change -2.31% -3.5%
% of Gross Profit 17.91% 7.32%
Operating Expenses $22.67M $21.41M
YoY Change 5.91% -8.01%
Operating Profit -$15.60M -$3.691M
YoY Change 322.62% -33.67%
Interest Expense $2.161M $1.274M
YoY Change 69.62% -39.71%
% of Operating Profit
Other Income/Expense, Net -$2.161M -$1.063M
YoY Change 103.29% -144.42%
Pretax Income -$17.76M -$4.754M
YoY Change 273.58% 49.87%
Income Tax $390.0K -$4.042M
% Of Pretax Income
Net Earnings -$18.15M -$712.0K
YoY Change 2449.16% -72.47%
Net Earnings / Revenue -18.12% -0.68%
Basic Earnings Per Share -$0.79 -$0.03
Diluted Earnings Per Share -$0.79 -$0.03
COMMON SHARES
Basic Shares Outstanding 22.89M shares 22.86M shares
Diluted Shares Outstanding 22.89M shares 22.86M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.40M $816.0K
YoY Change 2768.14% 81500.0%
Cash & Equivalents $23.40M $816.0K
Short-Term Investments
Other Short-Term Assets $11.16M $7.608M
YoY Change 46.74% -68.6%
Inventory $109.1M $125.6M
Prepaid Expenses
Receivables $52.53M $58.96M
Other Receivables $3.705M $3.808M
Total Short-Term Assets $200.1M $201.4M
YoY Change -0.63% -7.81%
LONG-TERM ASSETS
Property, Plant & Equipment $35.58M $22.71M
YoY Change 56.65% -4.73%
Goodwill $29.80M $29.84M
YoY Change -0.12% 0.12%
Intangibles $9.685M $12.61M
YoY Change -23.18% -21.69%
Long-Term Investments
YoY Change
Other Assets $19.99M $23.47M
YoY Change -14.82% -9.67%
Total Long-Term Assets $78.91M $88.62M
YoY Change -10.96% -7.45%
TOTAL ASSETS
Total Short-Term Assets $200.1M $201.4M
Total Long-Term Assets $78.91M $88.62M
Total Assets $279.1M $290.0M
YoY Change -3.79% -7.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.15M $67.31M
YoY Change -18.07% -21.03%
Accrued Expenses $29.36M $33.51M
YoY Change -12.39% -12.76%
Deferred Revenue $32.98M $36.67M
YoY Change -10.07% 366.42%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $292.0K $55.16M
YoY Change -99.47% 57356.25%
Total Short-Term Liabilities $251.9M $214.9M
YoY Change 17.22% -8.6%
LONG-TERM LIABILITIES
Long-Term Debt $695.0K $896.0K
YoY Change -22.43% -98.38%
Other Long-Term Liabilities $34.06M $28.89M
YoY Change 17.87% -7.15%
Total Long-Term Liabilities $34.75M $29.79M
YoY Change 16.66% -65.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $251.9M $214.9M
Total Long-Term Liabilities $34.75M $29.79M
Total Liabilities $291.0M $262.1M
YoY Change 11.03% -21.81%
SHAREHOLDERS EQUITY
Retained Earnings -$168.0M -$127.6M
YoY Change 31.67% -7.35%
Common Stock $23.00K $23.00K
YoY Change 0.0% 21.05%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.295M $10.15M
YoY Change -87.24% -0.74%
Treasury Stock Shares 225.0K shares 259.0K shares
Shareholders Equity -$11.95M $27.94M
YoY Change
Total Liabilities & Shareholders Equity $279.1M $290.0M
YoY Change -3.79% -7.7%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$18.15M -$712.0K
YoY Change 2449.16% -72.47%
Depreciation, Depletion And Amortization $1.266M $1.296M
YoY Change -2.31% -3.5%
Cash From Operating Activities $5.681M $24.30M
YoY Change -76.63% -3567.05%
INVESTING ACTIVITIES
Capital Expenditures -$617.0K -$779.0K
YoY Change -20.8% -4.53%
Acquisitions
YoY Change
Other Investing Activities -$10.00K -$7.000K
YoY Change 42.86%
Cash From Investing Activities -$607.0K -$772.0K
YoY Change -21.37% -5.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$2.638M -$22.72M
YoY Change -88.39% -1651.84%
NET CHANGE
Cash From Operating Activities $5.681M $24.30M
Cash From Investing Activities -$607.0K -$772.0K
Cash From Financing Activities -$2.638M -$22.72M
Net Change In Cash $2.436M $813.0K
YoY Change 199.63% -1633.96%
FREE CASH FLOW
Cash From Operating Activities $5.681M $24.30M
Capital Expenditures -$617.0K -$779.0K
Free Cash Flow $6.298M $25.08M
YoY Change -74.89% 21711.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
POWER SOLUTIONS INTERNATIONAL, INC.
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001137091
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22892413 shares
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherAccruedLiabilitiesCurrent
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherAccruedLiabilitiesCurrent
CY2021Q1 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:LongTermDebtCurrent
CY2020Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:LongTermDebtCurrent
CY2021Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2021Q1 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:LongTermDebtNoncurrent
CY2020Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:LongTermDebtNoncurrent
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23404000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20968000 USD
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
3299000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3299000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3269000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3701000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
52527000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60148000 USD
CY2021Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3705000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3708000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
109092000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
108213000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8115000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6351000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
200142000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
202687000 USD
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
19400000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
20181000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9685000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10319000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
29835000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
29835000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19992000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20955000 USD
CY2021Q1 us-gaap Assets
Assets
279054000 USD
CY2020Q4 us-gaap Assets
Assets
283977000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
55150000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31547000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
292000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
310000 USD
CY2021Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
130000000 USD
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
130000000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
66465000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
77619000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
251907000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
239476000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1255000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
886000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
695000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
781000 USD
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3087000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3181000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
34055000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33556000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
290999000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
277880000 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23117000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23117000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22892000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22892000 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
23000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
23000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
157371000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
157262000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-168044000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-149894000 USD
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
225000 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
225000 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1295000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1294000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-11945000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6097000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
279054000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
283977000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100171000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105097000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
93101000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
87383000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
7070000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
17714000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6224000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6752000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15811000 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13890000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
634000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
763000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
22669000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
21405000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-15599000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3691000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
2161000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
1274000 USD
CY2021Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2020Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
211000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2161000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1063000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17760000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4754000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
390000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4042000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18150000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-712000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22892000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22858000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22892000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22858000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6097000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18150000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
109000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-11945000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
28497000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-712000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
157000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
27941000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18150000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-712000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
634000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
763000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
1266000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
1296000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
109000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
157000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1158000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
116000 USD
CY2021Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
369000 USD
CY2020Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-390000 USD
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
574000 USD
CY2020Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-162000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7620000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-45585000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1363000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16811000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
84000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5530000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
24287000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-8586000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-11144000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9694000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
405000 USD
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1116000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5681000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24304000 USD
CY2021Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
617000 USD
CY2020Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
779000 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-10000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-7000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-607000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-772000 USD
CY2021Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
CY2020Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
127560000 USD
CY2021Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
CY2020Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
150258000 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2536000 USD
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-102000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-21000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2638000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22719000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2436000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
813000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24267000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26703000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
816000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23404000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
816000 USD
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
3299000 USD
CY2020Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26703000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
816000 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 psix Number Of Board Members
NumberOfBoardMembers
4 boardMember
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions include the valuation of allowances for uncollectible receivables, inventory reserves, warranty reserves, evaluation of goodwill, other intangibles, property, plant and equipment for impairment, and determination of useful lives of long-lived assets. Actual results could materially differ from those estimates.
CY2021Q1 psix Research And Development Expense Excluding Engineering
ResearchAndDevelopmentExpenseExcludingEngineering
6000000.0 USD
CY2020Q1 psix Research And Development Expense Excluding Engineering
ResearchAndDevelopmentExpenseExcludingEngineering
6400000 USD
CY2021Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2300000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3300000 USD
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
3300000 USD
CY2021Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
85595000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
89684000 USD
CY2021Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
6552000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2482000 USD
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20653000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
19375000 USD
CY2021Q1 us-gaap Inventory Gross
InventoryGross
112800000 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
111541000 USD
CY2021Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3708000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3328000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
109092000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
108213000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3328000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2964000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
553000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
526000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
173000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
273000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3708000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3217000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
17073000 USD
CY2020Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
14928000 USD
CY2021Q1 us-gaap Litigation Reserve
LitigationReserve
4129000 USD
CY2020Q4 us-gaap Litigation Reserve
LitigationReserve
3128000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
32978000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
47960000 USD
CY2021Q1 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
3172000 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
3124000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3809000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3793000 USD
CY2021Q1 us-gaap Interest Payable Current
InterestPayableCurrent
33000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
895000 USD
CY2021Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
5271000 USD
CY2020Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3791000 USD
CY2021Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
66465000 USD
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
77619000 USD
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
31542000 USD
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
25501000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
4630000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2325000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
4119000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
661000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
5166000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3926000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
35125000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
24561000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
17073000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
14027000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
18052000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
10534000 USD
CY2021Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
6800000 USD
CY2020Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
1700000 USD
CY2021Q1 psix Product Warranty Recoveries
ProductWarrantyRecoveries
1900000 USD
CY2020Q1 psix Product Warranty Recoveries
ProductWarrantyRecoveries
1200000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
4100000 USD
CY2021Q1 psix Standard Product Warranty Accrual Earnings Per Share Diluted
StandardProductWarrantyAccrualEarningsPerShareDiluted
0.18
CY2020Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
700000 USD
CY2020Q1 psix Standard Product Warranty Accrual Earnings Per Share Diluted
StandardProductWarrantyAccrualEarningsPerShareDiluted
0.03
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100171000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105097000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100171000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105097000 USD
CY2021Q1 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
250000 USD
CY2020Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
547000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32978000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
47960000 USD
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3087000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3181000 USD
CY2021Q1 psix Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-35815000 USD
CY2020Q4 psix Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-50594000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14900000 USD
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3000000.0 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
35700000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
32500000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
700000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1000000.0 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1000000.0 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
400000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
100000 USD
CY2021Q1 psix Collaborative Arrangement Inventory Purchased Goods
CollaborativeArrangementInventoryPurchasedGoods
3100000 USD
CY2020Q1 psix Collaborative Arrangement Inventory Purchased Goods
CollaborativeArrangementInventoryPurchasedGoods
5100000 USD
CY2021Q1 psix Collaborative Arrangement Accounts Payable
CollaborativeArrangementAccountsPayable
5000000.0 USD
CY2020Q4 psix Collaborative Arrangement Accounts Payable
CollaborativeArrangementAccountsPayable
4000000.0 USD
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
51269000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
51425000 USD
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
31869000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
31244000 USD
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
19400000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
20181000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
29800000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
29800000 USD
CY2020Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
11600000 USD
CY2021Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
11600000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
37340000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27655000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9685000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
37340000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27021000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10319000 USD
CY2021Q1 psix Finance Lease Liability And Other Long Term Debt
FinanceLeaseLiabilityAndOtherLongTermDebt
987000 USD
CY2020Q4 psix Finance Lease Liability And Other Long Term Debt
FinanceLeaseLiabilityAndOtherLongTermDebt
1091000 USD
CY2021Q1 psix Long Term Debt And Finance Lease Liability
LongTermDebtAndFinanceLeaseLiability
987000 USD
CY2020Q4 psix Long Term Debt And Finance Lease Liability
LongTermDebtAndFinanceLeaseLiability
1091000 USD
CY2021Q1 psix Long Term Debt Current Maturities And Finance Lease Liability Current
LongTermDebtCurrentMaturitiesAndFinanceLeaseLiabilityCurrent
292000 USD
CY2020Q4 psix Long Term Debt Current Maturities And Finance Lease Liability Current
LongTermDebtCurrentMaturitiesAndFinanceLeaseLiabilityCurrent
310000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
695000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
781000 USD
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1242000 USD
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1379000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
52000 USD
CY2020Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
52000 USD
CY2021Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
10000 USD
CY2020Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
13000 USD
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
102000 USD
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
110000 USD
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
338000 USD
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
423000 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
1744000 USD
CY2020Q1 us-gaap Lease Cost
LeaseCost
1977000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1257000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1373000 USD
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.067
CY2021Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
10000 USD
CY2020Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
13000 USD
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
51000 USD
CY2020Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
48000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M6D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y2M12D
CY2021Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.071
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.071
CY2021Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.067
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16177000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17104000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3809000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3793000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13197000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14156000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
17006000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
17949000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
508000 USD
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
568000 USD
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
198000 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
200000 USD
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
357000 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
413000 USD
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
555000 USD
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
613000 USD
CY2021Q1 psix Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
5546000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3691000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
184000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4788000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
177000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3283000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
103000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1813000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
84000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1851000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
62000 USD
CY2021Q1 psix Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
16000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20972000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
626000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3966000 USD
CY2021Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
71000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
17006000 USD
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
555000 USD
CY2020Q1 us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
30000000 USD
CY2021Q1 psix Number Of Outstanding Letters Of Credit
NumberOfOutstandingLettersOfCredit
6 letterOfCredit
CY2021Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2300000 USD
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
3300000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
0 shares
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
225000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22892000 shares
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.022
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.850
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23117000 shares
CY2021Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
0 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23117000 shares
CY2021Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
225000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22892000 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18150000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-712000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22892000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22858000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22892000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22858000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares

Files In Submission

Name View Source Status
0001137091-21-000005-index-headers.html Edgar Link pending
0001137091-21-000005-index.html Edgar Link pending
0001137091-21-000005.txt Edgar Link pending
0001137091-21-000005-xbrl.zip Edgar Link pending
exhibit311-ceocertificatio.htm Edgar Link pending
exhibit312-cfocertificatio.htm Edgar Link pending
exhibit321-ceocertificatio.htm Edgar Link pending
exhibit322-cfocertificatio.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
psix-20210331.htm Edgar Link pending
psix-20210331.xsd Edgar Link pending
psix-20210331_cal.xml Edgar Link unprocessable
psix-20210331_def.xml Edgar Link unprocessable
psix-20210331_g1.jpg Edgar Link pending
psix-20210331_htm.xml Edgar Link completed
psix-20210331_lab.xml Edgar Link unprocessable
psix-20210331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending